Statins in homozygous familial hypercholesterolemia

@article{Marais2002StatinsIH,
  title={Statins in homozygous familial hypercholesterolemia},
  author={Adrian David Marais and Dirk Jacobus Blom and Jean Catherine Firth},
  journal={Current Atherosclerosis Reports},
  year={2002},
  volume={4},
  pages={19-25}
}
  • Adrian David Marais, Dirk Jacobus Blom, Jean Catherine Firth
  • Published 2002
  • Medicine
  • Current Atherosclerosis Reports
    • Homozygous familial hypercholesterolemia is a rare disorder resulting in severe premature atherosclerosis. Drug therapy was previously viewed as inadequate for control of the dyslipidemia, so portacaval shunting, plasmapheresis, and liver transplantation were undertaken to treat this condition. Despite these drastic measures, additional cholesterol-lowering treatment may still be required. Furthermore, there is a need for pharmacologic control until additional measures can be undertaken. The… CONTINUE READING
    View on Springer
    ncbi.nlm.nih.gov
    Top 3 of 26 Citations
    Current Treatment of Famil ial Hypercholesterolaemia
    Cameron T Lambert, Prat ik Sandesara, … Laurence Sperl2014
    Homozygous familial hypercholesterolemia: current perspectives on diagnosis and treatment.
    Frederick J. Raal, Raul D. SantosAtherosclerosis2012
    240
    Current management of severe homozygous hypercholesterolaemias
    Rossitza P. Naoumova, Gilbert R. Thompson, Anne K. SoutarCurrent opinion in lipidology2004
    76

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 26 CITATIONS, ESTIMATED 69% COVERAGE

    Current Treatment of Famil ial Hypercholesterolaemia

    Homozygous familial hypercholesterolemia: current perspectives on diagnosis and treatment.

    VIEW 2 EXCERPTS
    CITES BACKGROUND

    Current management of severe homozygous hypercholesterolaemias

    Review of the scientific evolution of gene therapy for the treatment of homozygous familial hypercholesterolaemia: past, present and future perspectives

    Treatment of homozygous familial hypercholesterolemia

    Reduction in Mortality in Subjects With Homozygous Familial Hypercholesterolemia Associated With Advances in Lipid-Lowering Therapy

    What are we able to achieve today for our patients with homozygous familial hypercholesterolaemia, and what are the unmet needs?

    VIEW 1 EXCERPT
    CITES BACKGROUND

    Lipoprotein Apheresis in the Management of Familial Hypercholesterolaemia: Historical Perspective and Recent Advances

    Atypical Presentation and Treatment Response in a Child with Familial Hypercholesterolemia Having a Novel LDLR Mutation.

    VIEW 1 EXCERPT
    CITES BACKGROUND

    Familial hypercholesterolemia and estimation of US patients eligible for low-density lipoprotein apheresis after maximally tolerated lipid-lowering therapy.

    FILTER CITATIONS BY YEAR

    2003
    2019